ATB Therapeutics a biopharmaceutical company advancing next-generation antibody-based therapies for oncology and immunology, announced the appointment of Mark Throsby, PhD, as Chief Executive Officer. The...
Servier has announced the completion of its acquisition of Day One Biopharmaceuticals, which is valued at roughly $2.5 billion. It represents a key milestone...
CenterWell Senior Primary Care® and Conviva Senior Primary Care® have partnered with Thyme Care to deliver comprehensive cancer care support for eligible patients across...
Tevogen announced that its artificial intelligence initiative, Tevogen.AI, is expanding its collaboration with Microsoft and Databricks, to build the beta version of its foundational...
Calidi Biotherapeutics, a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, announced the appointment of Guy Travis Clifton, MD as Chief...
